Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Mol Immunol. 2012 Nov 3;53(4):443–449. doi: 10.1016/j.molimm.2012.10.002

Fig. 7.

Fig. 7

Survival curves of mice challenged with a lethal dose of LPS. S100A8 (n = 40) or PAR2 AP (n = 40) alone significantly increased the survival when administered intraperitoneally 4h after LPS (n = 40) from 33% to 65% and 63%, respectively (P < 0.01). The combination of PAR2 AP and S100A8 (n = 20) resulted in a survival rate of 85%. Which was statistically higher than with each alone (P < 0.05).